Suppr超能文献

血小板中的细胞黏附机制。

Cell adhesion mechanisms in platelets.

作者信息

Varga-Szabo David, Pleines Irina, Nieswandt Bernhard

机构信息

Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, Zinklesweg 10, 97078 Würzburg, Germany.

出版信息

Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):403-12. doi: 10.1161/ATVBAHA.107.150474. Epub 2008 Jan 3.

Abstract

At sites of vascular injury, platelets come into contact with the subendothelial extracellular matrix which triggers their activation and the formation of a hemostatic plug. This process is crucial for normal hemostasis, but may also lead to pathological thrombus formation causing diseases such as myocardial infarction or stroke. The initial capture of flowing platelets is mediated by the interaction of the glycoprotein (GP) Ib-V-IX complex with von Willebrand factor (vWF) immobilized on exposed collagens. This interaction allows the binding of the collagen receptor GPVI to its ligand and to initiate cellular activation, a process that is reinforced by locally produced thrombin and soluble mediators released from platelets. These events lead to the shift of beta1 and beta3 integrins on the platelet surface from a low to a high affinity state, thereby enabling them to bind their ligands and to mediate firm adhesion, spreading, coagulant activity, and aggregation. This review summarizes the most important structural and functional properties of these adhesion receptors and briefly discusses their potential as targets for antithrombotic therapy.

摘要

在血管损伤部位,血小板与内皮下细胞外基质接触,这会触发血小板的激活并形成止血栓。这一过程对于正常止血至关重要,但也可能导致病理性血栓形成,引发诸如心肌梗死或中风等疾病。流动血小板的初始捕获是由糖蛋白(GP)Ib-V-IX复合物与固定在暴露胶原上的血管性血友病因子(vWF)之间的相互作用介导的。这种相互作用使得胶原受体GPVI与其配体结合并启动细胞激活,这一过程会因局部产生的凝血酶和血小板释放的可溶性介质而得到加强。这些事件导致血小板表面的β1和β3整合素从低亲和力状态转变为高亲和力状态,从而使它们能够结合其配体并介导牢固黏附、铺展、凝血活性和聚集。本综述总结了这些黏附受体最重要的结构和功能特性,并简要讨论了它们作为抗血栓治疗靶点的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验